SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTII - Miscellaneous
NTII 0.00010000.0%Nov 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy9/26/2005 7:56:39 PM
   of 1296
 
2005 - "have lost weight easily"

SEVERE EDIT - link at bottom

Worse, he says that consuming MSG is addictive: "People will not experience withdrawal symptoms as seen with heroin, but they will crave glutamate-enhanced foods over unenhanced foods."


Other researchers agree. Michael Hermanussen, M.D., a pediatrician in Germany, says the amounts of glutamate found in nature aren't the problem; it's the glutamates we add to much of what we eat and drink that cause overeating. Hermanussen has been conducting a study using Memantine, a drug usually used to treat Alzheimer's disease, for weight control, and all of his subjects, he says, have lost weight easily.


Memantine is a member of the class of drugs called glutamate blockers, which keep MSG from reaching glutamate receptors in the brain. Ajinomoto's pharmaceutical arm, Ajinomoto Pharma, partners with a company called Daiichi Pharmaceuticals. Daiichi partners with Merz Pharmaceuticals.

And Merz produces Memantine. The same company that produces a food additive linked to neurological damage and obesity is also involved in producing a drug that can block the effects of that additive after we consume it.

sptimes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext